Cas:5581-42-0 Glyparamide manufacturer & supplier

Chemical Name:Glyparamide

CAS.NO:5581-42-0

Synonyms:Benzenesulfonamide,4-chloro-N-(((4-(dimethylamino)phenyl)amino)carbonyl);1-((p-chlorophenyl)sulfonyl)-3-(p-(dimethylamino)phenyl)urea;1-(4-Chlor-benzolsulfonyl)-3-(4-dimethylamino-phenyl)-harnstoff;P-1306;Glyparamide;Glyparamide (USAN)

Molecular Formula:C₁₅H₁₆ClN₃O₃S

Molecular Weight:353.82400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.41g/cm3

Index of Refraction:1.638

PSA:86.89000

Exact Mass:353.06000

LogP:4.46110

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzenesulfonamide,4-chloro-N-(((4-(dimethylamino)phenyl)amino)carbonyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Glyparamide (USAN) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Glyparamide Use and application,Benzenesulfonamide,4-chloro-N-(((4-(dimethylamino)phenyl)amino)carbonyl) technical grade,usp/ep/jp grade.

Related News: Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. Glyparamide manufacturer As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. Glyparamide supplier Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. Glyparamide vendor The continuous acceleration of the industrial transfer process has provided a huge market space for the fine chemical intermediate industry. Glyparamide factory As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.